About
Dopraxis is an independent resource on the emerging evidence, safety questions, and regulatory context surrounding ibogaine research in Parkinson’s disease. It distinguishes preliminary findings from established care.
Scope: evidence, uncertainty, safety awareness, and plain-language context.
Why this resource exists
Dopraxis exists for people who want a calm, careful place to orient themselves when information is incomplete, fast-moving, or difficult to compare. Our purpose is to separate what is known, what is being explored, and what has not been established.
The site is built as an independent reference about ibogaine research in Parkinson’s, with material arranged so readers can move from the core research-status overview to focused pages without treating any single page as a recommendation or a substitute for clinical care.
We recognize that people come to this subject with different questions. Some may be comparing discussions of ibogaine and ayahuasca; others may encounter material about ibogaine for alcohol addiction or ibogaine for PTSD treatment. Those subjects do not establish answers for the focus of this resource.
Our editorial approach
We organize information around traceable source types: research registries, published literature, official public materials, and clearly identified context. Trial records are treated as records of study activity, not proof that a treatment works; the ClinicalTrials.gov study registry is one example of a primary public record that can help readers distinguish a planned or listed study from a conclusion.
Published findings are read with attention to study design, population, outcomes, limitations, and whether results have been independently replicated. This reflects the broader expectation that clinical studies follow defined ethical and scientific standards, including the framework described in the World Medical Association’s Declaration of Helsinki.
-
01
Start with the recordWe look for the underlying registry entry, publication, or official material before relying on summaries.
-
02
Keep status visibleEarly observations, hypotheses, and established findings are not presented as if they carry the same weight.
-
03
State the limitsWhere sources are incomplete, unavailable, or inconclusive, that uncertainty belongs in the explanation.
What we cover
Dopraxis organizes material into focused paths for evidence, safety considerations, and research developments. The ways the resource can help orient a reader explain the site’s practical scope without presenting services as medical or legal guidance.
Context sometimes includes the public conversations readers may encounter elsewhere, such as Texas discussion around ibogaine, ibogaine treatment in Europe, or Mexico retreat information. These references are included as context for navigating claims, not as endorsements, referrals, or treatment direction.
Information specification
Rev. 01| Primary focus | Emerging evidence, safety questions, and regulatory context. |
|---|---|
| Source standard | Traceable records and appropriately qualified public sources. |
| Reader promise | Clear distinctions between preliminary findings and established care. |
| Not provided | Medical advice, legal advice, treatment selection, or provider referrals. |
Who this is for
This resource is for people affected by Parkinson’s, care partners, and others who want a careful understanding of early research without hype. It is also for readers who need help recognizing the difference between research information and promotional claims.
Readers may encounter accounts of ibogaine and Parkinson’s, descriptions of ibogaine detox centers, or other treatment-oriented material online. Dopraxis does not evaluate or direct readers to providers, centers, retreats, or programs.
“Evidence over hype means making uncertainty visible rather than filling gaps with confidence.”
Dopraxis principle
Editorial principles
Our approach is guided by a small set of practical principles. We aim to make source quality legible and to avoid overstating what a record can support. For readers checking published biomedical research, the PubMed literature database provides a recognized route to citation-level records and abstracts.
- 01 / EvidenceWe prioritize traceable information over persuasive claims.
- 02 / UncertaintyWe name open questions, limits, and missing information directly.
- 03 / SafetyWe keep safety awareness in view without giving clinical direction.
- 04 / LanguageWe use plain wording so important distinctions remain accessible.
- 05 / IndependenceWe do not operate as a clinic, treatment center, or referral service.
- 06 / ContextWe separate broad online discussion from evidence that can support a conclusion.
Independent by design
Dopraxis is an independent information resource. It is not a clinic, medical provider, licensed treatment center, or legal authority, and its content is not medical or legal advice.
We do not make treatment decisions, assess individual circumstances, or recommend programs. Where readers need personal medical guidance, a qualified clinician is the appropriate source; where legal questions arise, readers should seek qualified legal advice.
Information
Resource Evidence over hype
Clear uncertainty
Safety awareness